These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4095048)

  • 21. Nebulisers in the treatment of asthma.
    Drug Ther Bull; 1987 Dec; 25(26):101-3. PubMed ID: 3322761
    [No Abstract]   [Full Text] [Related]  

  • 22. Direct isotopic assessment of aerosolized pentamidine deposition: influence of nebuliser.
    Diot P; Le Pape A; Becquemin MH; Besnier JM; Boissinot E; Bastides F; Benjemaa M; Choutet P; Lemarie E
    Eur J Med; 1993; 2(8):484-8. PubMed ID: 8258049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of two commercial jet nebulisers and three compressors for the nebulisation of antibiotics.
    Hung JC; Hambleton G; Super M
    Arch Dis Child; 1994 Oct; 71(4):335-8. PubMed ID: 7979528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A mathematical model of some aspects of jet nebuliser performance.
    Smye SW; Jollie MI; Littlewood JM
    Clin Phys Physiol Meas; 1991 Aug; 12(3):289-300. PubMed ID: 1934916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nebulisers in domiciliary practice.
    Lancet; 1984 Dec; 2(8414):1281-2. PubMed ID: 6150312
    [No Abstract]   [Full Text] [Related]  

  • 26. Nebulisers: uses and abuses.
    Newman SP; Clarke SW
    Arch Dis Child; 1986 May; 61(5):424-5. PubMed ID: 3717987
    [No Abstract]   [Full Text] [Related]  

  • 27. Combinations of colistin solutions and nebulisers for lung infection management in cystic fibrosis patients.
    Buttini F; Rossi I; Di Cuia M; Rossi A; Colombo G; Elviri L; Sonvico F; Balducci AG
    Int J Pharm; 2016 Apr; 502(1-2):242-8. PubMed ID: 26854429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is the flow rate used to drive a jet nebuliser clinically important?
    Douglas JG; Leslie MJ; Crompton GK; Grant IW
    Br Med J (Clin Res Ed); 1985 Jan; 290(6461):29. PubMed ID: 2856895
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacokinetic and tolerability profiles of tobramycin nebuliser solution 300 mg/4 ml administered by PARI eFlow(®) rapid and PARI LC Plus(®) nebulisers in cystic fibrosis patients.
    Govoni M; Poli G; Acerbi D; Santoro D; Cicirello H; Annoni O; Ružička J
    Pulm Pharmacol Ther; 2013 Apr; 26(2):249-55. PubMed ID: 23232039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhaler mishandling is very common in patients with chronic airflow obstruction and long-term home nebuliser use.
    Melani AS; Canessa P; Coloretti I; DeAngelis G; DeTullio R; Del Donno M; Giacobbe R; Scarlato I; Serafini A; Barbato N; Vaghi A; Sestini P;
    Respir Med; 2012 May; 106(5):668-76. PubMed ID: 22277996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microbial contamination of domiciliary nebulisers and clinical implications in chronic obstructive pulmonary disease.
    Jarvis S; Ind PW; Thomas C; Goonesekera S; Haffenden R; Abdolrasouli A; Fiorentino F; Shiner RJ
    BMJ Open Respir Res; 2014; 1(1):e000018. PubMed ID: 25478172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patients' practices and experiences of using nebuliser therapy in the management of COPD at home.
    Alhaddad B; Smith FJ; Robertson T; Watman G; Taylor KM
    BMJ Open Respir Res; 2015; 2(1):e000076. PubMed ID: 25806114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Home nebuliser use in children with asthma in two Scottish Health Board Areas.
    Madge PJ; Nisbet L; McColl JH; Vallance A; Paton JY; Beattie JO
    Scott Med J; 1995 Oct; 40(5):141-3. PubMed ID: 8578301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nebuliser therapy.
    Esmond G
    Prof Nurse; 1998 Oct; 14(1):39-43. PubMed ID: 9866617
    [No Abstract]   [Full Text] [Related]  

  • 35. [Nebuliser therapy].
    Demir G; Saryal S
    Tuberk Toraks; 2003; 51(3):325-32. PubMed ID: 15143414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Aerosol therapy].
    Wildhaber JH
    Schweiz Med Wochenschr; 1998 Aug; 128(33):1223-8. PubMed ID: 9757487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fungal contamination of nebuliser devices used by people with cystic fibrosis.
    Peckham D; Williams K; Wynne S; Denton M; Pollard K; Barton R
    J Cyst Fibros; 2016 Jan; 15(1):74-7. PubMed ID: 26104996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Nebuliser delivery of berodual in patients with bronchial asthma and chronic obstructive bronchitis].
    Iakushin SS; Smirnova EA
    Klin Med (Mosk); 1999; 77(7):49. PubMed ID: 10483167
    [No Abstract]   [Full Text] [Related]  

  • 39. A randomised controlled trial to assess the relative benefits of large volume spacers and nebulisers to treat acute asthma in hospital.
    Dewar AL; Stewart A; Cogswell JJ; Connett GJ
    Arch Dis Child; 1999 May; 80(5):421-3. PubMed ID: 10208945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of the need to coat particle collection cups of the NGI to mitigate droplet bounce when evaluating nebuliser-produced droplets.
    Berg E; Lamb P; Ali A; Dennis J; Tservistas M; Mitchell J
    Pharmeur Sci Notes; 2008 Feb; 2008(1):21-5. PubMed ID: 18430403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.